B cells and the antibodies they secrete are increasingly recognised as more than bystanders in the immune response to Mycobacterium tuberculosis (Mtb). Beyond antigen presentation and support for T ...
A new study conducted by researchers from the German Rheumatology Research Center Berlin, an institute of the Leibniz Association, and the Charité—Universitätsmedizin Berlin has shed new light on how ...
The research highlights how NAV-005 overcomes the immunosuppressive effects that tumor-produced CA125 has on antibodies ...
The product is expected to be available in early 2026. The Food and Drug Administration (FDA) has approved Qivigy (immune globulin intravenous [IV], human-kthm) 10% solution for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results